FLI1 and systemic sclerosis: In the present study, we investigated the effects of miR-26a and its predicted target gene, FLI1, on dermal fibrosis in SSc patients, and their roles in the protective effects of BSYJ on dermal fibrosis using SFBs and a mouse model of SSc.